First Trust Advisors’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-25,661
Closed -$416K 2512
2021
Q1
$416K Buy
25,661
+7,708
+43% +$125K ﹤0.01% 2262
2020
Q4
$380K Sell
17,953
-28,496
-61% -$603K ﹤0.01% 2179
2020
Q3
$688K Buy
46,449
+22,398
+93% +$332K ﹤0.01% 1915
2020
Q2
$354K Sell
24,051
-65,204
-73% -$960K ﹤0.01% 2105
2020
Q1
$1.05M Buy
89,255
+65,735
+279% +$772K ﹤0.01% 1598
2019
Q4
$553K Buy
+23,520
New +$553K ﹤0.01% 2086
2019
Q2
Sell
-75,331
Closed -$1.84M 2470
2019
Q1
$1.84M Buy
75,331
+4,335
+6% +$106K ﹤0.01% 1594
2018
Q4
$1.84M Sell
70,996
-70,149
-50% -$1.82M ﹤0.01% 1530
2018
Q3
$4.47M Sell
141,145
-3,615
-2% -$114K 0.01% 1213
2018
Q2
$5.62M Buy
+144,760
New +$5.62M 0.01% 1033